YEM Search

搜索结果

PER1

靶点ID:TCMBANKGE009997

靶点别名:PER; RIGUI; hPER

靶点描述:period circadian regulator 1

染色体:17

染色体位置:17p13.1

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:8845

OMIM_Link:602260

Ensembl_Link:ENSG00000179094

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN016334	(-)-noradrenaline	to_000024; 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-; KBio3_001579; CHEBI:18357; NCGC00159406-02; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; Levoarterenol; KBio2_006625; KBio1_000230; L-Noradrenaline; NCGC00159406-05; Nor adrenalin (TN); Nor adrenalin; Noradrenaline (JP15); NINDS_000230; 4-[(1R)-2-amino-1-hydroxy-ethyl]pyrocatechol; Spectrum_001009; norepinephrinum; SPECTRUM1500436; KBio2_004057; Spectrum3_000520; KBio2_001489; DivK1c_000230; nchembio705-1; PDSP1_001111; 4-[(1R)-2-amino-1-hydroxy-ethyl]benzene-1,2-diol; 51-41-2; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-; KBioSS_001489; C00547; NCGC00159406-04; BSPBio_002079; AIDS335520; A7257_SIGMA; KBioGR_000635; D00076; (−)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(-)-; Spectrum5_001068; Arterenol; Spectrum4_000078; PDSP2_001095; Spectrum2_001064; (-)-(R)-Norepinephrine; SGCUT00123; AIDS-335520; Norepinephrine (INN); SPBio_001048; IDI1_000230	C8H11NO3	169.18	C1=CC(=C(C=C1C(CN)O)O)O
TCMBANKIN022518	noradrenaline	l-Norepinephrine bitartrate; 33404-26-1; l-Arterenol d-bitartrate; Norepinephrine hydrogen tartrate; 350-25-4; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt); API0007150; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 341N180; L(+)-TARTARIC ACID; NOREPINEPHRINE; Noradrenalin bitartrate, l-; Arterenol bitartrate; Noradrenaline acid tartrate; MolPort-029-943-999; Norartrinal bitartrate; Levarterenol; ZW81GF408B; Norepinephrine bitartrate anhydrous; L-Noradrenaline bitartrate; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bitartrate salt; AKOS007930222; Noradrenaline, tartrate (1:1); Norepinephrine tartrate; 73-98-3; Noradrenaline bitartrate; Noradrenaline tartrate; l-Noradrenaline tartrate; UNII-ZW81GF408B; C8H11NO3.C4H6O6; (-)-Norepinephrine bitartrate; (-)-Noradrenaline (+)-bitartrate; BG01031160; 51-40-1; 2477-42-1; Levonorepinephrine; 2595AH; l-Noradrenaline d-bitartrate; Noradrenaline hydrogen tartrate; HMS2089E22; (-)-R-Norepinephrine bitartrate; NSC 169106; 51-41-2 (Parent); API0003624; norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R,R))-2,3-dihydroxybutanedioate (1:1); l-Arterenol bitartrate; Levarterenol bitartrate; Noradrenalin bitartrate; L-(-)-Noradrenaline (+)-bitartrate salt monohydrate; BENZYL ALCOHOL, alpha-(AMINOMETHYL)-3,4-DIHYDROXY-, (-)-, TARTRATE (1:1); 24868-01-7; 893-91-4; EINECS 200-095-0	C8H12NO3+	170.19 g/mol	C1=CC(=C(C=C1C(C[NH3+])O)O)O
TCMBANKIN042107	Adrenaline	adrenaline		219.66 g/mol
TCMBANKIN057905	ferrum	iron	Fe	55.84 g/mol	[Fe]
TCMBANKIN057911	se	selenium	H2Se	78.97 g/mol	[Se]
TCMBANKIN058990	forskolin	coleonol	C22H34O7	410.5 g/mol	CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000009	Neoplasms	Abnormality of the nervous system; Neoplasm	Neoplastic Process	disease
TCMBANKDI000018	Digestive System Diseases; Neoplasms; Endocrine System Diseases	Abnormality of the digestive system; Neoplasm	Neoplastic Process	disease
TCMBANKDI000054	Nervous System Diseases; Mental Disorders	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI000107	Behavior and Behavior Mechanisms	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI000166	-	-	Neoplastic Process	disease
TCMBANKDI003248	Nutritional and Metabolic Diseases; Endocrine System Diseases	Abnormality of metabolism/homeostasis; Abnormality of the endocrine system	Disease or Syndrome	disease
TCMBANKDI003353	Pathological Conditions, Signs and Symptoms; Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI003411	-	-	Disease or Syndrome	disease
TCMBANKDI004195	Chemically-Induced Disorders; Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI004576	Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI006612	Neoplasms; Female Urogenital Diseases and Pregnancy Complications	Abnormality of the genitourinary system; Neoplasm	Neoplastic Process	disease
TCMBANKDI008172	-	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI009572	Nutritional and Metabolic Diseases	Abnormality of metabolism/homeostasis	Disease or Syndrome	phenotype
TCMBANKDI009702	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	phenotype
TCMBANKDI011173	Neoplasms	-	Neoplastic Process	disease
TCMBANKDI011743	Neoplasms; Skin and Connective Tissue Diseases	Neoplasm; Abnormality of the breast	Neoplastic Process	group
TCMBANKDI017024	Neoplasms; Respiratory Tract Diseases	-	Neoplastic Process	disease
TCMBANKDI017467	Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI017642	Neoplasms	Abnormality of the integument; Neoplasm	Neoplastic Process	disease
TCMBANKDI020559	Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases	-	Disease or Syndrome	disease
TCMBANKDI020911	Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases	-	Disease or Syndrome	disease
TCMBANKDI022574	Chemically-Induced Disorders; Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI024262	-	-	Neoplastic Process	phenotype
TCMBANKDI024535	Neoplasms; Respiratory Tract Diseases	Neoplasm; Abnormality of the respiratory system	Neoplastic Process	disease
TCMBANKDI026874	Infections	-	Disease or Syndrome	disease
TCMBANKDI032222	Nervous System Diseases; Mental Disorders	-	Mental or Behavioral Dysfunction	disease